leisure time -WSS

leisure time

author：entertainment 2025-09-06 05:56:30 Page View：2

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sanders adds drug shortage policies to pandemic preparedness bill
Next article： Psychedelics group wrestles with new pharma identity

leisure time

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

eGenesis tests gene

Agene-editedYucatanminipigcreatedbyeGenesis.CourtesyLizLinder/eGenesisForthreedaysinDecember,anICUro

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

Parkinson’s finding may lead to tests and, someday, treatments

CourtesyMarkSeligerNEWYORK— MichaelJ.FoxwassittinginhisUpperEastSideofficesurroundedbyEmmysandanOsca

leisure time

knowledge

leisure time

Parkinson’s finding may lead to tests and, someday, treatments